Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgical... by John M. Varlotto, MD, Yating Wang, MS, Zhuoxin Sun, PhD, Heather A. Wakelee, MD, Suresh Ramalingam, MD, Joan Schiller, MD

Get full text